Sun Pharma Outlook for the Week (March 14, 2022 – March 18, 2022)
SUNPHARMA Weekly Outlook and Analysis: For the Week: (March 14, 2022 – March 18, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
Tag : Sun Pharmaceutical Industries
Sun Pharma Outlook for the Week (March 07, 2022 – March 11, 2022)
SUNPHARMA Weekly Outlook and Analysis: For the Week: (March 07, 2022 – March 11, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
Sun Pharma Outlook for the Week (Feb 28, 2022 – March 04, 2022)
SUNPHARMA Weekly Outlook and Analysis: For the Week: (Feb 28, 2022 – March 04, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
Sun Pharma Outlook for the Week (Feb 21, 2022 – Feb 25, 2022)
SUNPHARMA Weekly Outlook and Analysis: For the Week: (Feb 21, 2022 – Feb 25, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
Sun Pharma Outlook for the Week (Feb 14, 2022 – Feb 18, 2022)
SUNPHARMA Weekly Outlook and Analysis: For the Week: (Feb 14, 2022 – Feb 18, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
Sun Pharma Outlook for the Week (Feb 07, 2022 – Feb 11, 2022)
SUNPHARMA Weekly Outlook and Analysis: For the Week: (Feb 07, 2022 – Feb 11, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
Sun Pharma Dips 3% on Profit Booking Post Q4 Result
Shares of Sun Pharmaceutical Industries fell 3 per cent to Rs 676 on the BSE in intra-day trade on Friday as investors booked profit after...
Sensex Hits Fresh Record High Led by Banking and IT Stocks
Sensex hit a record high of 41,185.03 points, and at 9.30 am it was 0.24 per cent higher at 41,108.48 points. Nifty climbed 0.3 per...
Pharma Shares Decline, Dr Reddy’s Lab down by 1%
On Wednesday’s morning session, Pharma shares were trading lower with their sectoral index trading lower. Shares of Cadila Healthcare down by 0.47 per cent, Dr...
Pharmaceutical Majors Recall Their Products From USA
According to the latest U.S. Food and Drug Administration’s (USFDA) Enforcement Report, Indian pharma major such as Lupin, Sun Pharma and Glenmark has decided to...
